Found: 16
Select item for more details and to access through your institution.
Oral arsenic plus imatinib versus imatinib solely for newly diagnosed chronic myeloid leukemia: a randomized phase 3 trial with 5-year outcomes.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2024, v. 150, n. 4, p. 1, doi. 10.1007/s00432-024-05700-x
- By:
- Publication type:
- Article
Efficacy of Tyrosine Kinase Inhibitor Combined with Decitabine, Homoharringtonine, Interferon in the Maintenance Therapy of Blast Phase Chronic Myeloid Leukemia.
- Published in:
- Journal of Experimental Hematology / Zhongguo Shiyan Xueyexue Zazhi, 2023, v. 31, n. 3, p. 649, doi. 10.19746/j.cnki.issn1009-2137.2023.03.005
- By:
- Publication type:
- Article
Regulatory Effect of As<sub>2</sub>O<sub>3</sub> on Imbalance between Adipogenic and Osteogenic Differentiation of BM-MSC from Patients with Aplastic Anemia.
- Published in:
- Journal of Experimental Hematology / Zhongguo Shiyan Xueyexue Zazhi, 2014, v. 22, n. 6, p. 1667, doi. 10.7534/j.issn.1009-2137.2014.06.031
- By:
- Publication type:
- Article
Hyperthermia Increases the Sensitivity of RPMI 8226 Cells to Adriamycin.
- Published in:
- Journal of Experimental Hematology / Zhongguo Shiyan Xueyexue Zazhi, 2011, v. 19, n. 3, p. 680
- By:
- Publication type:
- Article
Establishment of A Erythroleukemia Model in CB6F1 Mice by Transplant with Haploidentical Mouse Leukemic Cell Line FBL-3.
- Published in:
- Journal of Experimental Hematology / Zhongguo Shiyan Xueyexue Zazhi, 2010, v. 18, n. 5, p. 1128
- By:
- Publication type:
- Article
Biological Character of RetroNectin Activated Cytokine-Induced Killer Cells.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Haploidentical transplantation compared with matched sibling and unrelated donor transplantation for adults with standard-risk acute lymphoblastic leukaemia in first complete remission.
- Published in:
- British Journal of Haematology, 2017, v. 179, n. 1, p. 120, doi. 10.1111/bjh.14854
- By:
- Publication type:
- Article
Clinical observation of recombinant human endostatin in treating relapsed refractory multiple myeloma.
- Published in:
- Clinical & Experimental Pharmacology & Physiology, 2018, v. 45, n. 12, p. 1325, doi. 10.1111/1440-1681.13016
- By:
- Publication type:
- Article
Characterization of CD103+ CD8+ tissue-resident T cells in esophageal squamous cell carcinoma: may be tumor reactive and resurrected by anti-PD-1 blockade.
- Published in:
- Cancer Immunology, Immunotherapy, 2020, v. 69, n. 8, p. 1493, doi. 10.1007/s00262-020-02562-3
- By:
- Publication type:
- Article
Correlation between pre‐treatment serum carcinoembryonic antigen levels and genotypes in a large population of Chinese people with advanced lung adenocarcinoma.
- Published in:
- Internal Medicine Journal, 2019, v. 49, n. 5, p. 634, doi. 10.1111/imj.14152
- By:
- Publication type:
- Article
Retrospective analysis of the efficacy and influencing factors of autologous hematopoietic stem cell transplantation for multiple myeloma.
- Published in:
- Artificial Organs, 2019, v. 43, n. 10, p. 1028, doi. 10.1111/aor.13468
- By:
- Publication type:
- Article
Clinical and molecular features of Epstein‐Barr virus‐positive diffuse large B‐cell lymphoma: Results in a multi‐center trial.
- Published in:
- Clinical & Translational Medicine, 2021, v. 11, n. 9, p. 1, doi. 10.1002/ctm2.539
- By:
- Publication type:
- Article
The role of long non‐coding RNAs in multiple myeloma.
- Published in:
- European Journal of Haematology, 2019, v. 103, n. 1, p. 3, doi. 10.1111/ejh.13237
- By:
- Publication type:
- Article
Analysis of the efficacy and safety of bortezomib for treating newly diagnosed multiple myeloma through different administration methods.
- Published in:
- Cancer Management & Research, 2019, v. 11, p. 8295, doi. 10.2147/CMAR.S218979
- By:
- Publication type:
- Article
The consensus from The Chinese Society of Hematology on indications, conditioning regimens and donor selection for allogeneic hematopoietic stem cell transplantation: 2021 update.
- Published in:
- Journal of Hematology & Oncology, 2021, v. 14, n. 1, p. 1, doi. 10.1186/s13045-021-01159-2
- By:
- Publication type:
- Article
CEOP/IVE/GDP alternating regimen compared with CEOP as the first-line therapy for newly diagnosed patients with peripheral T cell lymphoma: results from a phase 2, multicenter, randomized, controlled clinical trial.
- Published in:
- Genome Medicine, 2020, v. 12, n. 1, p. 1, doi. 10.1186/s13073-020-00739-0
- By:
- Publication type:
- Article